Cipla Ltd. — Capital/Financing Update 2019

Feb 8, 2019

8th February, 2019

• (1) BSE Ltd Listing Department Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001
• (2) National Stock Exchange of India Ltd Listing Department Exchange Plaza, 5th floor, Plot no. C/1 , G Block, Bandra Kurla Complex, Sandra (East), Mumbai- 400 051

Scrip Code: 500087

Scrip Code: CIPLA EQ

(3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Dear Sirs,

This is further to our letter dated 131 h November 2018, we hereby notify that the Company's wholly owned subsidiary i.e. lnvaGen Pharmaceuticals Inc., USA has completed the first stage closing of the Avenue Therapeutics Inc. (Avenue), transaction representing an acquisition of 33.3% stake in Avenue's capital stock on fully diluted basis on 81 h February 2019.

Thank you,

For Cipla Limited

Rajendra Chopra Company Secretary

Prepared by: Kamlesh Kulkarni

• . -- :- ' ~ . ;